AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LUMOS DIAGNOSTICS HOLDINGS L

0.105

0.000

Volume:769.56K

Turnover:80.63K

Market Cap:99.16M

PE:-5.83

High:0.110

Open:0.110

Low:0.100

Close:0.105

52wk High:0.330

52wk Low:0.076

Shares:944.39M

Float Shares:375.60M

Volume Ratio:1.38

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.018

EPS(LYR):-0.011

ROE:-123.27%

ROA:-29.18%

PB:13.58

PE(LYR):-9.94

Loading ...

Overview Company News Filings

Australia's Lumos Diagnostics Soars on Bagging Purchase Order for Diagnostic Test

Lumos Diagnostics Receives Initial Blood Test Purchase Order Under Distribution Agreement; Shares Up 7%

MT Newswires Live

Lumos Diagnostics - Receives Us$767,800 Febridx Order from Phase Scientific

THOMSON REUTERS

Lumos Diagnostics Signs Exclusive Romania Distribution Agreement for Rapid Respiratory Infection Test; Shares Up 10%

MT Newswires Live

Lumos Diagnostics - Signs Exclusive Distribution Agreement for Febridx in Romania

THOMSON REUTERS

Lumos Diagnostics Posts FY26 Revenue Rises 6% to $13.2 Million

Lumos Diagnostics - FY26 Revenue Rises 6% to $13.2 Mln

THOMSON REUTERS

Lumos Diagnostics Advances US Commercialization for Rapid Test; Shares Down 3%

MT Newswires Live

Lumos Diagnostics Closes AU$5 Million Loan Facility With Two Shareholders

MT Newswires Live

Analysts Are Optimistic We'll See A Profit From Lumos Diagnostics Holdings Limited (ASX:LDX)

Simply Wall St.

Lumos Diagnostics Holdings Ltd-Investor Presentation - Febridx US Commercial Update

THOMSON REUTERS

Lumos Diagnostics Holdings Ltd-Febridx US Commercial Update Webinar Invitation

THOMSON REUTERS

Lumos Diagnostics Progresses Additional Pilot Sites With Urgent Care Operators For Respiratory Infection Testing Tool, Shares Jump 4%

MT Newswires Live

Lumos Diagnostics Holdings Ltd-Febridx U.S. Rollout and Reimbursement Update

THOMSON REUTERS

Lumos Diagnostics Hits Enrollment Milestone in Pediatric Clinical Study of Respiratory Infection Testing Tool; Shares Down 4%

MT Newswires Live

Lumos Diagnostics Holdings Receives Milestone Payment for Achieving CLIA Waiver

MT Newswires Live

Lumos Diagnostics Holdings Ltd-Results of Share Purchase Plan

THOMSON REUTERS

Insiders In Lumos Diagnostics Holdings Left Out From 11% Price Rise After Disposing Stock

Simply Wall St.

Lumos Diagnostics Expands FebriDx Test Rollout at WellStreet Urgent Care

MT Newswires Live

Lumos Diagnostics Receives $5 Million Prepayment From US Distribution Partner, Shares Up 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LDX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.105,"timestamp":1787292720000,"preClose":0.105,"halted":0,"volume":769561,"delay":0,"changeRate":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":944389135,"eps":-0.018,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.11,"high":0.11,"low":0.1,"amount":80625,"amplitude":0.095238,"askPrice":0.11,"askSize":224999,"bidPrice":0.1,"bidSize":1042244,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.105,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.3831890165727063,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LDX.AU","preClose":0.105,"auctionPrice":0.105,"auctionVolume":1129,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-29.18%","roe":"-123.27%","lyrEps":-0.01056,"volumeRatio":1.3831890165727063,"shares":944389135,"dividePrice":0,"high":0.11,"amplitude":0.095238,"preClose":0.105,"low":0.1,"week52Low":0.076,"pbRate":"13.58","psRate":"5.82","week52High":0.33,"institutionHeld":0,"latestPrice":0.105,"committee":0.6449,"eps":-0.018,"divideRate":0,"volume":769561,"delay":0,"ttmEps":-0.018,"open":0.11,"prevYearClose":0.285,"prevWeekClose":0.11,"prevMonthClose":0.1,"prevQuarterClose":0.105,"fiveDayClose":0.11,"twentyDayClose":0.11,"sixtyDayClose":0.115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-27","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785110400000,"name":null,"time":"","dateTimestamp":1785074400000,"actualEps":null},{"date":"2026-04-20","symbol":"LDX.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776643200000,"name":null,"time":"Post-Mkt","dateTimestamp":1776607200000,"actualEps":null},{"date":"2025-08-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656898675","title":"Australia's Lumos Diagnostics Soars on Bagging Purchase Order for Diagnostic Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2656898675","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656898675?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:32","pubTimestamp":1785810761,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test** Shares of Australia's Lumos DiagnosticsLDX.AXrise as much as 16.7% to A$0.123, hitting their biggest intraday p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4N44104S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656874586","title":"Lumos Diagnostics Receives Initial Blood Test Purchase Order Under Distribution Agreement; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656874586","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656874586?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:38","pubTimestamp":1785807496,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  received an initial $767,800 purchase order from Phase Scientific for its FebriDx blood test, satisfying part of the year one minimum order quantity commitment under a distribution agreement with Phase Scientific, according to a Tuesday Australian bourse filing.The order is associated with the $5 million prepayment milestone received by Lumos following the grant of the CLIA waiver for FebriDx by the US Food and Drug Administration on March 27.Product delivery is expected to be fulfilled progressively between Tuesday and October.The company's shares climbed nearly 7% in recent trading on Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300748","title":"Lumos Diagnostics - Receives Us$767,800 Febridx Order from Phase Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300748?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:04","pubTimestamp":1785798296,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44012M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655844138","title":"Lumos Diagnostics Signs Exclusive Romania Distribution Agreement for Rapid Respiratory Infection Test; Shares Up 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655844138","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655844138?lang=en_us&edition=fundamental","pubTime":"2026-07-30 12:00","pubTimestamp":1785384038,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has entered into an exclusive distribution agreement with Romania-based Alpha Medical to commercialize its FebriDx rapid point-of-care diagnostic test across Romania, according to a Thursday filing with the Australian bourse.Alpha Medical has already placed an initial stocking order to ensure the products are available for immediate supply, per the filing.The partnership expands the company's European distribution network, building on agreements with Henry Schein and Interlux to broaden access to FebriDx through experienced regional partners, the filing added.The company's shares rose around 10% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655848381","title":"Lumos Diagnostics - Signs Exclusive Distribution Agreement for Febridx in Romania","url":"https://stock-news.laohu8.com/highlight/detail?id=2655848381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655848381?lang=en_us&edition=fundamental","pubTime":"2026-07-30 07:38","pubTimestamp":1785368318,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V1RQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654309341","title":"Lumos Diagnostics Posts FY26 Revenue Rises 6% to $13.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2654309341","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654309341?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:41","pubTimestamp":1785116488,"startTime":"0","endTime":"0","summary":"July 27 (Reuters) - Lumos Diagnostics Holdings Ltd::*FY26 REVENUE RISES 6% TO $13.2 MILLION*Further company coverage: LDX.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 27-JUL-202601:34:36 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nRSD1JYm25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654609490","title":"Lumos Diagnostics - FY26 Revenue Rises 6% to $13.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2654609490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654609490?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:56","pubTimestamp":1785110210,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nFWN43R0H7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653223240","title":"Lumos Diagnostics Advances US Commercialization for Rapid Test; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653223240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653223240?lang=en_us&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601347,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  is advancing the commercialization strategy for its FebriDx rapid point-of-care test across its priority top 100 target list in the US, according to a Tuesday filing with the Australian bourse.The company is using a four-stage commercial framework to help track and communicate the progress of accounts, the filing said.FebriDx sales in the US are made through the company's exclusive distribution agreement with Phase Scientific, per the filing.Shares fell 3% in midday trade Tuesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648280571","title":"Lumos Diagnostics Closes AU$5 Million Loan Facility With Two Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2648280571","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648280571?lang=en_us&edition=fundamental","pubTime":"2026-07-02 14:00","pubTimestamp":1782972010,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  said it closed down a AU$5 million secured loan facility with shareholders Tenmile Ventures and Ryder Capital Management, according to a Thursday filing with the Australian bourse.Lumos previously drew AU$1 million under the facility, which was established in September 2025, and repaid the outstanding balance in full following the completion and receipt of AU$20 million of placement proceeds in April.The company said it currently has no debt.Its shares gained 2% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644162034","title":"Analysts Are Optimistic We'll See A Profit From Lumos Diagnostics Holdings Limited (ASX:LDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644162034","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644162034?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:51","pubTimestamp":1781819508,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Lumos Diagnostics Holdings Limited's ( ASX:LDX ) business as it appears...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/analysts-are-optimistic-well-see-a-profit-from-lumos-diagnos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/analysts-are-optimistic-well-see-a-profit-from-lumos-diagnos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642294474","title":"Lumos Diagnostics Holdings Ltd-Investor Presentation - Febridx US Commercial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2642294474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642294474?lang=en_us&edition=fundamental","pubTime":"2026-06-11 07:58","pubTimestamp":1781135937,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUE9VBXJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640334261","title":"Lumos Diagnostics Holdings Ltd-Febridx US Commercial Update Webinar Invitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2640334261","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640334261?lang=en_us&edition=fundamental","pubTime":"2026-06-04 09:23","pubTimestamp":1780536235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUE5P2230:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636483690","title":"Lumos Diagnostics Progresses Additional Pilot Sites With Urgent Care Operators For Respiratory Infection Testing Tool, Shares Jump 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636483690","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636483690?lang=en_us&edition=fundamental","pubTime":"2026-05-18 09:46","pubTimestamp":1779068781,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  progressed numerous additional pilot sites with new urgent care operators/chains for its FebriDx rapid point-of-care test for acute respiratory infections, according to a Monday Australian bourse filing.The eight urgent care chains run by new operator ownership groups are progressing favourably in their evaluation and implementation of FebriDx, it added.Lumos is also receiving regular reimbursement updates through its consultants, PRO-spectus and AcuityMD, and is beginning to see early data from sites using FebriDx, which suggests that over 90% of submitted claims are being reimbursed.Its shares rose 4% in recent trading on Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636901283","title":"Lumos Diagnostics Holdings Ltd-Febridx U.S. Rollout and Reimbursement Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2636901283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636901283?lang=en_us&edition=fundamental","pubTime":"2026-05-18 07:49","pubTimestamp":1779061790,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260517:nTUE6BZFQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635763820","title":"Lumos Diagnostics Hits Enrollment Milestone in Pediatric Clinical Study of Respiratory Infection Testing Tool; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635763820","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635763820?lang=en_us&edition=fundamental","pubTime":"2026-05-14 09:40","pubTimestamp":1778722841,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  completed the enrollment of 250 patients in the Biomedical Advanced Research and Development Authority -funded pediatric clinical study of the FebriDx rapid point-of-care test for acute respiratory infections, according to a Thursday Australian bourse filling.This triggered a $670,000 milestone payment under Lumos' agreement with BARDA, bringing the total milestone payments received to date to $2.6 million, the filing said.The study is evaluating the use of the FebriDx device in children between the ages of two to 12 years to differentiate bacterial from non-bacterial acute respiratory infections, per the filing. It is expected to run for around 12 months.Lumos Diagnostics Holdings' shares tumbled 4% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633913581","title":"Lumos Diagnostics Holdings Receives Milestone Payment for Achieving CLIA Waiver","url":"https://stock-news.laohu8.com/highlight/detail?id=2633913581","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633913581?lang=en_us&edition=fundamental","pubTime":"2026-05-07 13:41","pubTimestamp":1778132474,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  received a milestone payment of $507,377, under its contract with the Biomedical Advanced Research and Development Authority  for achieving US Food and Drug Administration  CLIA waiver for its FebriDx rapid point-of-care test, according to a Thursday Australian bourse filing.The receipt of the payment from BARDA brings the total amount received under the CLIA waiver study to almost $3 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU","CLIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632695468","title":"Lumos Diagnostics Holdings Ltd-Results of Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2632695468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632695468?lang=en_us&edition=fundamental","pubTime":"2026-05-01 09:04","pubTimestamp":1777597474,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nTUEBPJNTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628473394","title":"Insiders In Lumos Diagnostics Holdings Left Out From 11% Price Rise After Disposing Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2628473394","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628473394?lang=en_us&edition=fundamental","pubTime":"2026-04-18 08:15","pubTimestamp":1776471332,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings Limited's (ASX:LDX) stock rose 11% last week, but insiders who sold US$428k worth of stock...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/insiders-in-lumos-diagnostics-holdings-left-out-from-11-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/insiders-in-lumos-diagnostics-holdings-left-out-from-11-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627494658","title":"Lumos Diagnostics Expands FebriDx Test Rollout at WellStreet Urgent Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2627494658","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627494658?lang=en_us&edition=fundamental","pubTime":"2026-04-14 13:26","pubTimestamp":1776144405,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has expanded an agreement with WellStreet Urgent Care to roll out its FebriDx rapid point-of-care test to an additional 43 locations from a single initial site, according to a Tuesday filing with the Australian bourse.The expanded rollout will take place over the next two months, and once it is completed, Lumos expects WellStreet to launch FebriDx at all of the remaining outlets in its network of 163 urgent care locations, per the filing.The increased volume and enhanced payor visibility from the expanded rollout should also strengthen the company's position in future contract negotiations with other health care providers, Lumos said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627460149","title":"Lumos Diagnostics Receives $5 Million Prepayment From US Distribution Partner, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627460149","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627460149?lang=en_us&edition=fundamental","pubTime":"2026-04-14 09:21","pubTimestamp":1776129696,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  has received a $5 million prepayment for product from US distribution partner PHASE Scientific, confirming that the US Food and Drug Administration's 510 clearance with CLIA waiver for FebriDx product satisfies the milestone requirements of the PHASE distribution agreement, according to a Tuesday Australian bourse filing.The company said the $5 million represents a prepayment for future sales and will be recorded as revenue when the product is shipped, the filing added.The company's shares rose 3% in recent Tuesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}